Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zealand Pharma A/S

    NASDAQ: ZEAL · Real-Time Price · USD
    17.59
    0.00 (0.00%)
    At close: Sep 29, 2022, 8:00 PM

    Zealand Pharma A/S Statistics

    Share Statistics

    Zealand Pharma A/S has 0 shares outstanding. The number of shares has increased by -0.6% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 -0.6%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -5.26 and the forward PE ratio is null. Zealand Pharma A/S's PEG ratio is -0.26.

    PE Ratio

    n/a
    		 -5.26

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 18.3

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 5.77

    P/FCF Ratio

    n/a
    		 -4.34

    PEG Ratio

    n/a
    		 -0.26
    Financial Ratio History

    Enterprise Valuation

    Zealand Pharma A/S has an Enterprise Value (EV) of 5.01B.

    EV / Sales

    n/a
    		 17.13

    EV / EBITDA

    n/a
    		 -5.1

    EV / EBIT

    n/a
    		 -4.13

    EV / FCF

    n/a
    		 -4.06

    Financial Position

    The company has a current ratio of 5.15, with a Debt / Equity ratio of 0.85.

    Current Ratio

    n/a
    		 5.15

    Quick Ratio

    n/a
    		 4.8

    Debt / Equity

    n/a
    		 0.85

    Debt / EBITDA

    n/a
    		 -0.8

    Debt / FCF

    n/a
    		 -0.64

    Interest Coverage

    n/a
    		 -250.02

    Financial Efficiency

    Return on Equity is -109.74% and Return on Invested Capital is -59.12%.

    Return on Equity

    n/a
    		 -109.74%

    Return on Assets

    n/a
    		 -49.24%

    Return on Invested Capital

    n/a
    		 -59.12%

    Revenue Per Employee

    n/a
    		 $1,234,459.92

    Profits Per Employee

    n/a
    		 $-4,295,987.34

    Employee Count

    n/a
    		 237

    Asset Turnover

    n/a
    		 0.14

    Inventory Turnover

    n/a
    		 1

    Taxes

    Income Tax

    n/a
    		 -8.79M

    Effective Tax Rate

    n/a
    		 0.86%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.34, so Zealand Pharma A/S's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.34

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 17.62

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 49.2

    Average Volume (20 Days)

    n/a
    		 1,758

    Income Statement

    In the last 12 months, Zealand Pharma A/S had revenue of 292.57M and earned -1.02B in profits. Earnings per share was -26.54.

    Revenue

    n/a
    		 292.57M

    Gross Profit

    n/a
    		 173.75M

    Operating Income

    n/a
    		 -1.02B

    Net Income

    n/a
    		 -1.02B

    EBITDA

    n/a
    		 -982.6M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -26.54
    Full Income Statement

    Balance Sheet

    The company has 1.13B in cash and 787.43M in debt, giving a net cash position of 341.67M.

    Cash & Cash Equivalents

    n/a
    		 1.13B

    Total Debt

    n/a
    		 787.43M

    Net Cash

    n/a
    		 341.67M

    Retained Earnings

    n/a
    		 -3.31B

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.21B and capital expenditures -22.13M, giving a free cash flow of -1.23B.

    Operating Cash Flow

    n/a
    		 -1.21B

    Capital Expenditures

    n/a
    		 -22.13M

    Free Cash Flow

    n/a
    		 -1.23B

    FCF Per Share

    n/a
    		 -32.16
    Full Cash Flow Statement

    Margins

    Gross margin is 59.39%, with operating and profit margins of -349.61% and -348.01%.

    Gross Margin

    n/a
    		 59.39%

    Operating Margin

    n/a
    		 -349.61%

    Pretax Margin

    n/a
    		 -351.01%

    Profit Margin

    n/a
    		 -348.01%

    EBITDA Margin

    n/a
    		 -335.85%

    EBIT Margin

    n/a
    		 -349.61%

    FCF Margin

    n/a
    		 -421.82%

    Dividends & Yields

    ZEAL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -19.02%

    FCF Yield

    n/a
    		 -23.06%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ZEAL.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist